SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-23-000028
Filing Date
2023-01-19
Accepted
2023-01-19 15:41:42
Documents
52
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp123122form10q.htm   iXBRL 10-Q 1132657
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 36001
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 38195
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 16900
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 9486
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 9486
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 4226
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 4103
  Complete submission text file 0001607062-23-000028.txt   4031201

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE rgbp-20221231.xsd EX-101.SCH 45151
10 XBRL CALCULATION FILE rgbp-20221231_cal.xml EX-101.CAL 48546
11 XBRL DEFINITION FILE rgbp-20221231_def.xml EX-101.DEF 126897
12 XBRL LABEL FILE rgbp-20221231_lab.xml EX-101.LAB 250578
13 XBRL PRESENTATION FILE rgbp-20221231_pre.xml EX-101.PRE 196205
46 EXTRACTED XBRL INSTANCE DOCUMENT rgbp123122form10q_htm.xml XML 389778
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 23537373
SIC: 2834 Pharmaceutical Preparations